proadifen has been researched along with Lung Neoplasms in 5 studies
Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.
Lung Neoplasms: Tumors or cancer of the LUNG.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Garnett, DJ | 1 |
Bolton, JL | 1 |
Thompson, JA | 1 |
Allentoff, AJ | 1 |
Miley, FB | 1 |
Malkinson, AM | 1 |
Smith, GB | 1 |
Castonguay, A | 1 |
Donnelly, PJ | 1 |
Reid, KR | 1 |
Petsikas, D | 1 |
Massey, TE | 1 |
Dzhioev, FK | 1 |
Balanski, RM | 1 |
Yamamoto, RS | 1 |
Weisburger, JH | 1 |
Weisburger, EK | 1 |
5 other studies available for proadifen and Lung Neoplasms
Article | Year |
---|---|
Caveolae as a target to quench autoinduction of the metastatic phenotype in lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Caveolae; Caveolin 1; Cell Line, Tumo | 2016 |
Metabolic activation of butylated hydroxytoluene by mouse bronchiolar Clara cells.
Topics: Animals; Biotransformation; Butylated Hydroxytoluene; Female; Lung; Lung Neoplasms; Male; Mice; Proa | 1993 |
Biotransformation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in freshly isolated human lung cells.
Topics: Aged; Biotransformation; Carcinogens; Female; Humans; Hydroxylation; Inactivation, Metabolic; Lung; | 1999 |
[Inhibition of urethane carcinogenesis by antioxidants and carbon tetrachloride].
Topics: Adenoma; Administration, Oral; Animals; Antioxidants; Carbon Tetrachloride; Cell Transformation, Neo | 1974 |
Controlling factors in urethan carcinogenesis in mice: effect of enzyme inducers and metabolic inhibitors.
Topics: Animals; Body Weight; Chlordan; Cycloheximide; Dactinomycin; Flavonoids; Hematocrit; Lung Neoplasms; | 1971 |